{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:13:10Z","timestamp":1787962390424,"version":"build-2784847793"},"reference-count":52,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1043519"],"award-info":[{"award-number":["APP1043519"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.vaccine.2016.03.089","type":"journal-article","created":{"date-parts":[[2016,4,7]],"date-time":"2016-04-07T11:18:22Z","timestamp":1460027902000},"page":"2608-2615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection"],"prefix":"10.1016","volume":"34","author":[{"given":"Kelly A.","family":"Prendergast","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Counoupas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbert","family":"Bitter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Triccas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.03.089_bib0265","series-title":"Global tuberculosis report 2015","year":"2015"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0270","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis: meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0275","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018523","article-title":"Novel vaccination strategies against tuberculosis","volume":"4","author":"Andersen","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0280","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.vaccine.2012.12.053","article-title":"Safety and immunogenicity of the recombinant BCG vaccine VPM1002 in a phase 1 open-label randomized clinical trial","volume":"31","author":"Grode","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0285","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.vaccine.2010.12.135","article-title":"Ag85B-ESAT-6 adjuvanted with IC31(R) promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection","volume":"29","author":"van Dissel","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0290","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.vaccine.2009.10.114","article-title":"Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen","volume":"28","author":"Skeiky","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0295","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0300","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0305","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(13)60177-4","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","volume":"381","author":"Tameris","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0310","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1016\/j.vaccine.2013.07.051","article-title":"Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials","volume":"31","author":"Arbues","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0315","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/MMBR.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0320","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1126\/science.276.5317.1420","article-title":"Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis","volume":"276","author":"Belisle","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0325","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1099\/mic.0.26226-0","article-title":"Cord factor trehalose 6,6\u2032-dimycolate (TDM) mediates trafficking events during mycobacterial infection of murine macrophages","volume":"149","author":"Indrigo","year":"2003","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0330","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1128\/IAI.67.7.3199-3206.1999","article-title":"Survival of Mycobacterium avium and Mycobacterium tuberculosis in acidified vacuoles of murine macrophages","volume":"67","author":"Gomes","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0335","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1128\/IAI.56.12.3046-3051.1988","article-title":"Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG","volume":"56","author":"Abou-Zeid","year":"1988","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0340","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/IAI.61.11.4828-4834.1993","article-title":"Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin","volume":"61","author":"Peake","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0345","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1074\/jbc.M111.298687","article-title":"Novel mycobacteria antigen 85 complex binding motif on fibronectin","volume":"287","author":"Kuo","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0350","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/IAI.70.3.1287-1292.2002","article-title":"Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages","volume":"70","author":"Pasula","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0355","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1172\/JCI118910","article-title":"Induction of monocyte expression of tumor necrosis factor alpha by the 30-kD alpha antigen of Mycobacterium tuberculosis and synergism with fibronectin","volume":"98","author":"Aung","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0360","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1462-5822.2007.00884.x","article-title":"The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice","volume":"9","author":"Palma","year":"2007","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0365","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/intimm\/dxg115","article-title":"Immunogenicity of peptide-25 of Ag85B in Th1 development: role of IFN-g","volume":"15","author":"Kariyone","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0370","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.micres.2007.04.006","article-title":"Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model","volume":"164","author":"Fan","year":"2009","journal-title":"Microbiol Res"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0375","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/intimm\/dxh170","article-title":"The role of antigenic peptide in CD4+ T helper phenotype development in a T cell receptor transgenic model","volume":"16","author":"Tamura","year":"2004","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0380","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.vaccine.2010.12.070","article-title":"Targeted induction of antigen expression within dendritic cells modulates antigen-specific immunity afforded by recombinant BCG","volume":"29","author":"Kong","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0385","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1099\/00221287-148-10-3007","article-title":"Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis","volume":"148","author":"Bardarov","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0390","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-59745-232-8_15","article-title":"Mycobacterial recombineering","volume":"435","author":"van Kessel","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0395","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nmeth996","article-title":"Recombineering in Mycobacterium tuberculosis","volume":"4","author":"van Kessel","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0400","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1111\/j.1600-0854.2008.00830.x","article-title":"Dynamic behaviour of Salmonella-induced membrane tubules in epithelial cells","volume":"9","author":"Drecktrah","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0405","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1574-6968.2008.01396.x","article-title":"The cell surface-exposed glycopeptidolipids confer a selective advantage to the smooth variants of Mycobacterium smegmatis in vitro","volume":"290","author":"Kocincova","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0410","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.dci.2007.04.003","article-title":"Identification and real-time imaging of a myc-expressing neutrophil population involved in inflammation and mycobacterial granuloma formation in zebrafish","volume":"32","author":"Meijer","year":"2008","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0415","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.4049\/jimmunol.179.6.3973","article-title":"Induction of CD8 T cells against a novel epitope in TB10.4: correlation with mycobacterial virulence and the presence of a functional region of difference-1","volume":"179","author":"Billeskov","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nprot.2011.438","article-title":"Intravital multiphoton imaging of immune responses in the mouse ear skin","volume":"7","author":"Li","year":"2012","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0425","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/eji.200939665","article-title":"Modulation of pulmonary DC function by vaccine-encoded GM-CSF enhances protective immunity against Mycobacterium tuberculosis infection","volume":"40","author":"Nambiar","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0430","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/eji.201141903","article-title":"Protective immunity afforded by attenuated, PhoP-deficient Mycobacterium tuberculosis is associated with sustained generation of CD4+ T-cell memory","volume":"42","author":"Nambiar","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0435","doi-asserted-by":"crossref","first-page":"563838","DOI":"10.1155\/2012\/563838","article-title":"Immunogenicity and protective efficacy of a novel recombinant BCG strain overexpressing antigens Ag85A and Ag85B","volume":"2012","author":"Wang","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0440","doi-asserted-by":"crossref","first-page":"5237","DOI":"10.1016\/j.vaccine.2010.05.063","article-title":"Enhanced protection against tuberculosis by vaccination with recombinant BCG over-expressing HspX protein","volume":"28","author":"Shi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0445","doi-asserted-by":"crossref","first-page":"13853","DOI":"10.1073\/pnas.250480397","article-title":"Recombinant bacillus Calmette-Guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model","volume":"97","author":"Horwitz","year":"2000","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0450","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ejcb.2011.03.001","article-title":"Integrin-mediated uptake of fibronectin-binding bacteria","volume":"90","author":"Hoffmann","year":"2011","journal-title":"Eur J Cell Biol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0455","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0196-9781(03)00101-3","article-title":"Antiadhesive peptides as the inhibitors of Mycobacterium kansasii phagocytosis","volume":"24","author":"Siemion","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0460","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.4049\/jimmunol.179.4.2509","article-title":"Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo","volume":"179","author":"Wolf","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0465","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2005-03-1281","article-title":"Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes","volume":"106","author":"Abadie","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0470","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0475","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0480","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7774\/cevr.2014.3.2.155","article-title":"Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis","volume":"3","author":"Yuk","year":"2014","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0485","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1128\/IAI.72.12.7084-7095.2004","article-title":"A mutant of Mycobacterium tuberculosis H37Rv that lacks expression of antigen 85A is attenuated in mice but retains vaccinogenic potential","volume":"72","author":"Copenhaver","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0490","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/IAI.68.2.767-778.2000","article-title":"Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages","volume":"68","author":"Armitige","year":"2000","journal-title":"Infect Immun"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2016.03.089_bib0495","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.tube.2011.10.018","article-title":"The DeltafbpA attenuated candidate vaccine from Mycobacterium tuberculosis, H37Rv primes for a stronger T-bet dependent Th1 immunity in mice","volume":"91","author":"Roche","year":"2011","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0500","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.vaccine.2004.10.007","article-title":"Expanding the antigenic repertoire of BCG improves protective efficacy against aerosol Mycobacterium tuberculosis infection","volume":"23","author":"Palendira","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0505","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2567.2006.02355.x","article-title":"Expression levels of Mycobacterium tuberculosis antigen-encoding genes versus production levels of antigen-specific T cells during stationary level lung infection in mice","volume":"118","author":"Rogerson","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0510","first-page":"200","article-title":"Does the efficacy of BCG decline with time since vaccination","volume":"2","author":"Sterne","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17370","article-title":"Systemic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guerin vaccination against tuberculosis","volume":"17","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2016.03.089_bib0520","doi-asserted-by":"crossref","first-page":"e113951","DOI":"10.1371\/journal.pone.0113951","article-title":"Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice","volume":"9","author":"Nandakumar","year":"2014","journal-title":"PLoS One"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T08:32:01Z","timestamp":1600417921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":52,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0264410X1630086X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Ag85B protein of the BCG vaccine facilitates macrophage uptake but is dispensable for protection against aerosol Mycobacterium tuberculosis infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.03.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}